Lucia G. C.
- Country
- Spain
- Department
- Oncology
Research Overview
- A Phase III, Randomized, Double-blind Study to Evaluate Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy for Triple Negative Breast Cancer (TNBC)
- Efficacy and Safety of Giredestrant vs. Fulvestrant with CDK4/6 Inhibitor in ER+ HER2- Advanced Breast Cancer Resistant to Endocrine Therapy
- Evaluation of Healthcare and Patient Time Efficiency in Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab for HER2-Positive Early Breast Cancer
Data & Insights
Has run more than one trial at 232 of 471 partner sites.
Specializations
Breast Cancer Specialization
The investigator focuses extensively on advanced therapeutic approaches for various breast cancer subtypes, particularly HER2-positive, HER2-negative, and hormone receptor-positive breast cancer.
- Early-stage breast cancer treatment
- Metastatic breast cancer management
- Triple-negative breast cancer therapy
Research interests include novel combination therapies and targeted treatments for different breast cancer molecular subtypes.
Gynecologic Oncology
The investigator conducts research in gynecologic cancers, with particular emphasis on ovarian cancer and cervical cancer treatment modalities.
- Advanced ovarian cancer therapeutics
- Locally advanced cervical cancer treatment
- Neoadjuvant therapy approaches
Special focus on innovative treatment combinations and targeted therapeutic strategies for gynecologic malignancies.
Innovative Therapies
The investigator explores cutting-edge therapeutic approaches including immunotherapy and targeted molecular treatments.
- Novel drug combinations
- Immunotherapy applications
- Molecular targeted therapies
Research encompasses both early-phase and advanced clinical investigations of new therapeutic strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.